Latest Commercialization News

First Graphene Limited has responded to an ASX price query, attributing its recent share price and volume surge to increased buying activity in Germany linked to prior commercial announcements, while reaffirming full compliance with ASX disclosure rules.

Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.

ADX Energy has suspended testing at its Welchau-1 gas well in Upper Austria following a landmark Austrian Constitutional Court ruling that repealed a legal provision preventing environmental objections from halting operations. This development introduces regulatory uncertainty amid ongoing evaluation of the well’s potential.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.

Foresta Group Holdings secures a significant regulatory boost as its Kawerau renewable energy project is included in New Zealand’s Fast-Track Approvals Act 2024, expediting the path to construction and operation.

TMK Energy has successfully initiated gas flows from three new pilot wells at its Gurvantes XXXV Project, doubling total field production and advancing toward critical desorption pressures expected by mid-2025.

Syrah Resources has been awarded a US$165 million tax credit under the US Inflation Reduction Act to support the expansion of its Vidalia active anode material facility in Louisiana, potentially increasing production capacity to 45ktpa.

Unith Ltd has strengthened its financial position through a partial divestment in AudioStack while renewing a key public health contract and achieving its highest B2C subscription revenue in two years.

Pointerra has won a US$2 million contract extension from the US Department of Energy to expand its hurricane impact analysis program, leveraging its Pointerra3D digital twin technology to enhance electric grid resilience across North America.

Renergen has confirmed ongoing LNG production and helium liquefaction at its Phase 1 plant, addressing recent share price volatility and outlining plans to boost capacity through additional wells.

FBR Limited has received a substantial A$6.3 million R&D tax incentive rebate from the Australian Taxation Office, strengthening its financial position as it wraps up its US Demonstration Program with additional funding from CRH Ventures.